The Mainz Severity Score Index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease

被引：41

作者：

Beck, M ^{[1
]}

机构：

[1] Univ Mainz, Childrens Hosp, D-6500 Mainz, Germany

来源：

ACTA PAEDIATRICA | 2006年 / 95卷

关键词：

Fabry disease; MSSI;

D O I：

10.1080/08035320600618825

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Fabry disease is a rare lysosomal storage disorder caused by the deficient activity of the lysosomal enzyme a-galactosidase A. The resultant storage of undegraded glycolipids leads to the progressive development of potentially life-threatening manifestations affecting multiple organ systems in the body. This paper describes the development of the Mainz Severity Score Index (MSSI), a scoring system for patients with Fabry disease. Conclusion: The MSSI score has been proven to be representative in patients with 'classic' Fabry disease and may be useful for monitoring clinical improvement in patients receiving enzyme replacement therapy.

引用

页码：43 / 46

页数：4

共 50 条

[1] Inflammation in Fabry disease: Correlation with Mainz Severity Score Index (MSSI)
Rosa Neto, Nilton S.
Bento, Judith C. B.
Caparbo, Valeria F.
Pereira, Rosa Maria R.
MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S124 - S124
[2] THE ROLE OF THE MAINZ SEVERITY SCORE INDEX (MSSI) ON DISEASE RELATED-CLINICAL EVENTS IN PATIENTS WITH FABRY DISEASE
Cha, E.
Kim, E.
Musat, M.
Monfort, L.
Azimpour, K.
VALUE IN HEALTH, 2022, 25 (07) : S509 - S510
[3] Fabry disease: elevated prevalence of vertebral fractures and correlation with Mainz Severity Score Index
Rosa Neto, Nilton Salles
de Barros Bento, Judith Campos
Takayama, Liliam
Caparbo, Valeria de Falco
Rodrigues Pereira, Rosa Maria
JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 162 - 163
[4] DEVELOPMENT OF A DISEASE SEVERITY SCORING SYSTEM FOR ANDERSON-FABRY DISEASE
Giannini, E. H.
Wilcox, B.
CLINICAL THERAPEUTICS, 2008, 30 : S105 - S106
[5] Development of a disease severity scoring system for Anderson-Fabry disease
Giannini, Edward
Wilcox, Bill
MOLECULAR GENETICS AND METABOLISM, 2008, 93 (02) : S22 - S22
[6] A VALIDATED DISEASE SEVERITY SCORING SYSTEM FOR FABRY DISEASE
Wanner, Christoph
Giannini, Edward H.
Mehta, Atul B.
Hilz, Max J.
Beck, Michael
Bichet, Daniel G.
Brady, Roscoe O.
West, Michael
Germain, Dominique P.
Waldek, Stephen
Clarke, Joe T. R.
Mengel, Eugen
Strotmann, Joerg M.
Warnock, David G.
Linhart, Ales
CLINICAL THERAPEUTICS, 2010, 32 : S108 - S109
[7] A validated disease severity scoring system for Fabry disease
Waldek, Stephen
Giannini, Edward
Mehta, Atul
Hilz, Max
Beck, Michael
Bichet, Daniel
Brady, Roscoe
West, Michael
Germain, Dominique
Wanner, Christoph
Clarke, Joe
Warnock, David
Linhart, Ales
MOLECULAR GENETICS AND METABOLISM, 2010, 99 (02) : S37 - S37
[8] A validated disease severity scoring system for Fabry disease
Giannini, Edward H.
Mehta, Atul B.
Hilz, Max J.
Beck, Michael
Bichet, Daniel G.
Brady, Roscoe O.
West, Michael
Germain, Dominique P.
Wanner, Christoph
Waldek, Stephen
Clarke, Joe T. R.
Mengel, Eugen
Strotmann, Joerg M.
Warnock, David G.
Linhart, Ales
MOLECULAR GENETICS AND METABOLISM, 2010, 99 (03) : 283 - 290
[9] Fabry International Prognostic Index: a predictive severity score for Anderson-Fabry disease
Hughes, Derralynn A.
Malmenas, Mia
Deegan, Patrick B.
Elliott, Perry M.
Ginsberg, Lionel
Hajioff, Daniel
Ioannidis, Alex S.
Orteu, Catherine H.
Ramaswami, Uma
West, Michael
Pastores, Gregory M.
Jenkinson, Crispin
JOURNAL OF MEDICAL GENETICS, 2012, 49 (03) : 212 - 220
[10] The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy
Whybra, C
Kampmann, C
Krummenauer, F
Ries, M
Mengel, E
Miebach, E
Baehner, F
Kim, K
Bajbouj, M
Schwarting, A
Gal, A
Beck, M
CLINICAL GENETICS, 2004, 65 (04) : 299 - 307

← 1 2 3 4 5 →